This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Jayashree Bagchi Chakraborty: Innovator in Asthma Treatment
Introduction
Jayashree Bagchi Chakraborty is a prominent inventor based in Kolkata, India. She has made significant contributions to the field of medical research, particularly in the treatment of bronchial asthma. Her innovative work focuses on the development of compounds that inhibit specific pathways associated with asthma.
Latest Patents
Jayashree holds a patent for "Substituted catechols as inhibitors of IL-4 and IL-5 for the treatment of bronchial asthma." This invention relates to compounds of general formula 1, which are designed to treat bronchial asthma by inhibiting the IL-4 or IL-5 pathways. The patent outlines methods for administering these compounds through various routes, including oral, intranasal, or inhalation, to effectively reduce perivascular and peribronchial inflammation.
Career Highlights
Jayashree is affiliated with the Council of Scientific and Industrial Research, where she has been instrumental in advancing research in her field. Her dedication to innovation has led to the development of effective treatments for asthma, showcasing her commitment to improving patient outcomes.
Collaborations
She has collaborated with notable colleagues, including Bholanath Paul and Bikas Chandra Pal, to further her research efforts. These collaborations have enhanced the scope and impact of her work in the scientific community.
Conclusion
Jayashree Bagchi Chakraborty is a trailblazer in the field of asthma treatment, with her innovative patent contributing to significant advancements in medical science. Her work exemplifies the importance of research and collaboration in developing effective therapies for chronic conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
